HomeNewsBusinessMarketsGlenmark Pharma shares trade flat as Nirma to acquire majority stake in Glenmark Life
Trending Topics

Glenmark Pharma shares trade flat as Nirma to acquire majority stake in Glenmark Life

In September this year, Glenmark Pharmaceuticals said its board has approved to divest 75 per cent stake in its subsidiary GLS.

December 20, 2023 / 12:56 IST
Story continues below Advertisement
As of June 30, Glenmark Pharmaceuticals held an 82.84 percent stake in GLS.
As of June 30, Glenmark Pharmaceuticals held an 82.84 percent stake in GLS.

Glenmark Pharmaceuticals shares initially rose by 1.4 percent but later reversed their gains to trade slightly in the negative on December 20. This shift occurred after the Competition Commission of India (CCI) approved Nirma's acquisition of the majority shareholding in the subsidiary Glenmark Life Sciences.

"CCI approves acquisition of majority shareholding of Glenmark Life Sciences Limited by Nirma Ltd," the competition watchdog said in a post on social media platform X (formerly known as Twitter).

Story continues below Advertisement

Follow our market blog to catch all the live updates

The deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices as well as promotes fair competition in the marketplace.